Focal adhesion kinase inhibitor BI 853520 inhibits cell proliferation, migration and EMT process through PI3K/AKT/mTOR signaling pathway in ovarian cancer

Focal adhesion kinase (FAK) activation has been reported to be associated with cell progression and metastasis in a wide variety of cancer cells. Target treatment by inhibiting FAK has achieved remarkable effects in several cancers, but the effect in ovarian cancer has not been reported. In this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hong, Gao, Yizhi, Ren, Chenchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777525/
https://www.ncbi.nlm.nih.gov/pubmed/35201437
http://dx.doi.org/10.1007/s12672-021-00425-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777525/
https://www.ncbi.nlm.nih.gov/pubmed/35201437
http://dx.doi.org/10.1007/s12672-021-00425-6

Ejemplares similares